Harvesting of adequate progenitor cells after "double G-CSF" for autologous transplantation in myeloma.

被引：0
|
作者：
Sheekey, D [1 ]
Howe, T [1 ]
Nagesh, K [1 ]
Chopra, R [1 ]
Chang, J [1 ]
Morgenstern, GR [1 ]
Scarffe, JH [1 ]
机构：
[1] Christie Hosp NHS Trust, Dept Haematol Oncol, Manchester M20 4BX, Lancs, England
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
743
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [1] Outcomes of G-CSF alone vs G-CSF with upfront plerixafor vs G-CSF/chemotherapy for collection of autologous stem cells in patients with multiple myeloma.
    Talamo, Giampaolo
    George, Melissa
    Ehmann, W. Christopher
    Drabick, Joseph J.
    Mineishi, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Harvesting after G-CSF mobilization: Previous therapy with G-CSF decreases the number of circulating progenitor cells
    Olavarria, E
    Nevado, MI
    Estevez, L
    Prieto, E
    Roman, A
    Soto, C
    Lobo, F
    Paniagua, G
    Llorente, L
    Barbolla, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 931 - 931
  • [3] Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
    Tuazon, Sherilyn
    Daskalakis, Constantine
    Saini, Neeraj
    Mandala, Ashok
    O'Hara, William J.
    Sharma, Manish
    Filicko-O'Hara, Joanne
    Carabasi, Matthew
    Grosso, Dolores
    Alpdogan, Onder
    Martinez-Outschoorn, Ubaldo
    Kasner, Margaret
    Flomenberg, Neal
    Weiss, Mark
    Wagner, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S145 - S146
  • [4] Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial
    Bolwell, BJ
    Pohlman, B
    Andresen, S
    Kalaycio, M
    Goormastic, M
    Wise, K
    Wakeling, A
    Dannley, R
    Overmoyer, B
    BONE MARROW TRANSPLANTATION, 1998, 21 (04) : 369 - 373
  • [5] Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial
    BJ Bolwell
    B Pohlman
    S Andresen
    M Kalaycio
    M Goormastic
    K Wise
    A Wakeling
    R Dannley
    B Overmoyer
    Bone Marrow Transplantation, 1998, 21 : 369 - 373
  • [6] G-CSF instead of autologous stem cell transplantation after high dose melphalan as front-line therapy in multiple myeloma.
    Harousseau, JL
    Facon, T
    Maloisel, F
    DabouzHarrouche, F
    Witz, F
    Guilhot, F
    Archimbaud, E
    Desablens, B
    Abgrall, JF
    Linassier, C
    Grosbois, B
    Bancillon, A
    Badri, N
    Bataille, R
    BLOOD, 1995, 86 (10) : 725 - 725
  • [7] Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
    M Offidani
    L Corvatta
    A Olivieri
    S Rupoli
    J Frayfer
    A Mele
    E Manso
    M Montanari
    R Centurioni
    P Leoni
    Bone Marrow Transplantation, 1999, 24 : 1079 - 1087
  • [8] Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
    Offidani, M
    Corvatta, L
    Olivieri, A
    Rupoli, S
    Frayfer, J
    Mele, A
    Manso, E
    Montanari, M
    Centurioni, R
    Leoni, P
    BONE MARROW TRANSPLANTATION, 1999, 24 (10) : 1079 - 1087
  • [9] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    DiPersio, John F.
    Stadtmauer, Edward A.
    Nademanee, Auayporn
    Micallef, Ivana N. M.
    Stiff, Patrick J.
    Kaufman, Jonathan L.
    Maziarz, Richard T.
    Hosing, Chitra
    Frueehauf, Stefan
    Horwitz, Mitchell
    Cooper, Dennis
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2009, 113 (23) : 5720 - 5726
  • [10] Delayed G-CSF after autologous bone marrow transplantation
    Maiolino, A
    Biasoli, I
    Nucci, M
    Spector, N
    Pulcheri, W
    BONE MARROW TRANSPLANTATION, 1998, 22 (08) : 832 - 832
12345